home / stock / soph / soph news


SOPH News and Press, SOPHiA GENETICS SA From 11/10/25

Stock Information

Company Name: SOPHiA GENETICS SA
Stock Symbol: SOPH
Market: NASDAQ
Website: sophiagenetics.com

Menu

SOPH SOPH Quote SOPH Short SOPH News SOPH Articles SOPH Message Board
Get SOPH Alerts

News, Short Squeeze, Breakout and More Instantly...

SOPH - Tracking Al Gore's Generation Investment Management Portfolio - Q3 2025 Update

2025-11-10 22:52:38 ET This article is part of a series that provides an ongoing analysis of the changes made to Generation Investment Management's 13F portfolio on a quarterly basis. It is based on Al Gore's regulatory 13F Form filed on 11/10/2025. Please visit our Tracking Al Go...

SOPH - SOPHiA GENETICS SA (SOPH) Q3 2025 Earnings Call Transcript

2025-11-04 13:56:25 ET SOPHiA GENETICS SA (SOPH) Q3 2025 Earnings Call November 4, 2025 8:00 AM EST Company Participants Kellen Sanger - Head of Strategy and Investor Relations Jurgi Camblong - Co-Founder, CEO & Director Ross Muken - President George Card...

SOPH - FDA Opens the Door for AI in Clinics, Priming Market for $2.7T Digital Health Wave by 2035

2025-11-04 09:34:07 ET https://markets-headlines.com/wp-content/uploads/2025/11/FDA-Opens-the-Door-for-AI-in-Clinics-Priming-Market-for-2.7T-Digital-Health-Wave-by-2035-1.mp4 Issued on behalf of Aleen Inc. ...

SOPH - SOPHiA Genetics GAAP EPS of -$0.30 misses by $0.06, revenue of $19.5M beats by $1.37M

2025-11-04 07:54:10 ET More on SOPHiA Genetics Sophia Genetics Growth Story Clouded By Persistent Losses: Why I'm Choosing To Hold Seeking Alpha’s Quant Rating on SOPHiA Genetics Historical earnings data for SOPHiA Genetics Financial information for SO...

SOPH - SOPHiA GENETICS Reports Third Quarter 2025 Results and Increases 2025 Revenue Guidance

SOPHiA GENETICS Reports Third Quarter 2025 Results and Increases 2025 Revenue Guidance PR Newswire BOSTON and ROLLE, Switzerland , Nov. 4, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today reported financial resul...

SOPH - Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution

Highl ights Third quarter 2025 revenue of $205.7 million decreased by 4% year-over-year but was flat when excluding previously discussed headwinds 1 of $8.1 million , consistent with management expectations . Third quarter 2025 her...

SOPH - SOPHiA GENETICS to Announce Financial Results for Third Quarter 2025 on November 4, 2025

SOPHiA GENETICS to Announce Financial Results for Third Quarter 2025 on November 4, 2025 PR Newswire BOSTON and ROLLE, Switzerland , Oct. 21, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today announced it will r...

SOPH - A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in Japan

A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in Japan PR Newswire ROLLE, Switzerland and TOKYO , Oct. 16, 2025 /PRNewswire/ -- A.D.A.M. Innovations , Japan's leading private genetic ...

SOPH - Molecules, Machines & Markets: Biotech Booms, AI Accelerates, and Pain Relief Gets Personal

2025-10-16 09:30:04 ET DENVER, Colo., Oct 16, 2025 ( 247marketnews.com )- Wall Street opens today with biotech and AI stocks in sharp focus after a wave of clinical milestones, cutting-edge launches, and strategic shifts dominated headlines. Here’s what’s moving the market...

SOPH - SOPHiA GENETICS Launches AI-Powered Digital Twins to Enhance Intelligent Decision-Making in Oncology

SOPHiA GENETICS Launches AI-Powered Digital Twins to Enhance Intelligent Decision-Making in Oncology Canada NewsWire BOSTON and ROLLE, Switzerland , Oct. 16, 2025 /CNW/ -- SOPHiA GENETICS (Nasdaq: SOPH), a leader in AI-driven precision medicine, today announced the lau...

Previous 10 Next 10